Can a patient with hyperthyroidism continue taking methimazole (antithyroid medication) while having influenza?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Methimazole Use During Influenza

Yes, you should continue taking methimazole during influenza—there is no contraindication or interaction between methimazole and influenza infection or its treatment.

Key Clinical Principle

The management of hyperthyroidism with methimazole is independent of concurrent influenza infection. The provided evidence addresses influenza treatment protocols and methimazole safety profiles separately, with no documented interactions or contraindications between the two conditions 1, 2.

Rationale for Continuation

  • Methimazole discontinuation risks: Stopping methimazole abruptly can precipitate thyroid storm, a life-threatening complication with multiorgan dysfunction, as documented in cases where antithyroid therapy was interrupted 3.

  • No drug interactions: Influenza antiviral medications (neuraminidase inhibitors like oseltamivir, zanamivir, or peramivir) have no known interactions with methimazole 1.

  • No disease interaction: Influenza infection does not alter methimazole metabolism or increase risk of its known adverse effects (agranulocytosis, hepatotoxicity, vasculitis) 2, 4.

Important Monitoring Considerations

Watch for Agranulocytosis Symptoms

  • Critical warning: If you develop fever, sore throat, or severe malaise during influenza while on methimazole, seek immediate medical attention to differentiate between influenza symptoms and methimazole-induced agranulocytosis (occurs in 3 per 10,000 patients) 2, 4.

  • Timing matters: Agranulocytosis typically occurs within the first 3 months of methimazole therapy 4.

  • Diagnostic approach: A complete blood count (CBC) with differential should be obtained if there is clinical concern, as both influenza and agranulocytosis can present with fever and malaise 5.

Hepatotoxicity Monitoring

  • Baseline risk: Methimazole can cause hepatotoxicity, though less commonly than propylthiouracil 4, 3.

  • Influenza consideration: If you develop jaundice or severe abdominal pain, this requires immediate evaluation, as both methimazole hepatotoxicity and severe influenza complications need to be excluded 4, 3.

Influenza Treatment Recommendations

If you require influenza antiviral therapy while on methimazole:

  • Start antivirals promptly if you are hospitalized, have severe/progressive illness, are immunocompromised, have chronic medical conditions (including hyperthyroidism), are pregnant, or are under 2 years or over 65 years old 1.

  • Standard regimen: Oseltamivir (oral), zanamivir (inhaled), or peramivir (IV) for 5 days can be safely used with methimazole 1.

  • Bacterial coinfection: If you develop worsening symptoms after initial improvement or present with severe pneumonia, empirical antibiotics should be added (doxycycline or co-amoxiclav preferred) in addition to continuing both methimazole and influenza antivirals 1.

Common Pitfall to Avoid

Do not stop methimazole due to fever alone—fever is an expected symptom of influenza but also a warning sign of agranulocytosis. The distinction requires clinical judgment and laboratory testing (CBC), not empiric discontinuation 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hyperthyroidism with Thionamides

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Multiorgan dysfunction accompanied with metimazole and thyroid storm.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2012

Research

[Pharmacotherapy of hyperthyreosis--adverse drug reactions].

Therapeutische Umschau. Revue therapeutique, 2011

Research

Severe neutropenia as an adverse effect of methimazole in the treatment of hyperthyroidism.

Clinical excellence for nurse practitioners : the international journal of NPACE, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.